FDA label
What is Ofev used for?
Ofev contains nintedanib esylate. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label for Ofev lists 3 uses: Idiopathic Pulmonary Fibrosis; Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype; Systemic Sclerosis-Associated Interstitial Lung Disease.
Run it in Rivvi
Which 2027 plans near you dropped or restricted Ofev?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Ofev, capsule
Indications and Usage, quoted from the label by Boehringer Ingelheim Pharmaceuticals, Inc. (NDA205832). Cross-references to other label sections are left out.
Idiopathic Pulmonary Fibrosis
OFEV is indicated for the treatment of adults with idiopathic pulmonary fibrosis (IPF).
Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype
OFEV is indicated for the treatment of adults with chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype.
Systemic Sclerosis-Associated Interstitial Lung Disease
OFEV is indicated to slow the rate of decline in pulmonary function in adult patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD).
Source: DailyMed label, set id da1c9f37-779e-4682-816f-93d0faa4cfc9, version 21, effective November 20, 2025. NDC 0597-0143, one of 2 listings for this product.
Questions
What is Ofev used for?
The FDA label for Ofev lists 3 uses: Idiopathic Pulmonary Fibrosis; Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype; Systemic Sclerosis-Associated Interstitial Lung Disease.
What drug class is Ofev?
FDA lists nintedanib esylate in the Kinase Inhibitor established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.